FIG. 1.
Aspirin/clopidogrel (Asp/Clo) treatment diminishes liver disease severity. (A) sALT activity (units/liter means ± standard deviations) was measured at the indicated time points in mice (n = 8) that received either diluent or aspirin/clopidogrel and were infected or not with RAd35. Histological analyses of representative lacZ-immunized C57BL/6J mice treated with diluent (B) or Asp/Clo (C) and sacrificed 3 days after RAd35 infection are shown. (B and C) Scale bars, 150 μm.